MENA Microbiome
From Biomarkers Discovery
to Microbiota-based Therapeutics
Date: 28-29 September 2024Venue: Sidra Medicine Auditorium
Agenda
| 7:00 – 8:00 am | Registration/Check-in | |
| Time | Speaker | Talk Time |
| 8:00 – 8:10 am | Dr. Souhaila Al Khodor, MENA Microbiome Chair
Dr. Annalisa Terranegra, MENA Microbiome Chair Dr. Khalid Fakhro, Chief Research Officer, Sidra Medicine |
Welcome Notes |
| 8:10 – 8:15 am | TBC | |
| 8:15 – 8:30 am | Dr. Rayana Bou Haka Head of Office World Health Organization- Qatar Dr. Abdullatif Al Khal Deputy Chief Medical Officer Hamad Medical Corporation, Qatar |
Opening remarks |
| 8:30 – 8:45 am | TBC | TBC |
| 8:45 – 10:30 am | Session I: Keeping the balance between health and disease – Role of the Microbiome
Learning objectives:
Session Chairs:
|
|
| 8:45 – 9:30 am | Prof. Alessio Fasano Chief of the Division of Pediatric Gastroenterology and Nutrition Professor of Pediatrics, Harvard Medical School, MA, USA |
Keynote Lecture:
Microbiome, Gut Permeability, And Immune Response: The Triangulation Dictating the Balance Between Health and Disease |
| 9:30 – 9:55 am | Dr. Souhaila Al Khodor Director of the Reproductive and Perinatal Health Division Sidra Medicine, Qatar |
Multi-Omics of microbial and host factors for a better understanding of Pediatric Inflammatory Bowel Disease |
| 9:55 – 10:20 am | Dr. Farah Al-Marzooq Assistant Professor, Department of Medical Microbiology and Immunology United Arab Emirates University, UAE |
Salivary microbiome signature in patients with Crohn’s disease |
| 10:20 – 10:30 am | Short Oral Talk | O1 |
| 10:30 – 11:00 am | Coffee break
Poster viewing and exhibition visit |
|
| 11:00 am – 2:00 pm | Session II: Diet, Lifestyle & the Microbiome
Learning objectives:
Session Chairs:
|
|
| 11:00 – 11:25 am | Dr. Heli Viljakainen Group leader, Department of Food and Nutrition University of Helsinki, Finland |
Associations of central Childhood obesity and habitual food consumption with saliva microbiota and its enzymatic profiles. |
| 11:25 – 11:50 am | Dr. Vibeke H. Telle-Hansen Associate Professor Oslo Metropolitan University, Norway |
Testing the beneficial effect of PUFA on the microbiome and cholesterol levels in healthy individuals: A randomized crossover trial. |
| 11:50 am – 12:00 pm | Short Oral Talk | O2 |
| 12:00 – 1:00 pm | Lunch
Poster viewing and judging |
|
| 1:00 – 1:25 pm | Dr. Annalisa Terranegra Principal Investigator Precision Nutrition Sidra Medicine, Qatar |
Precision nutrition approach to pediatric type 1 diabetes |
| 1:25 – 1:50 pm | Dr. Mohammad T Albataineh Assistant Professor, Molecular Biology and Genetics, College of Medicine and Health Sciences Khalifa University, UAE |
Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers |
| 1:50 – 2:00 pm | Short Oral Talk | O3 |
| 2:00 – 4:35 pm | Session III: Bugs as drugs: Microbiome-based Therapeutics
Learning objectives:
Session Chairs:
|
|
| 2:00 – 2:25 pm | Dr. Amine Zorgani Founder – The Microbiome Mavericks Consultant Biocodex Microbiota Institute, Belgium |
Microbiome therapeutics: Past, Present, and Future |
| 2:25 – 2:50 pm | Dr. Mamoun Elawad Chief of the Division of Pediatric Gastroenterology and Nutrition Sidra Medicine, Qatar |
Faecal Material Transplantation in Inflammatory Bowel disease |
| 2:50 – 3:15 pm | Prof. Sunny Wong Associate Professor and Assistant Dean at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore |
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial |
| 3:15 – 3:45 pm | Coffee Break
Poster viewing and judging |
|
| 3:45 – 4:10 pm | Dr. Elisabetta Volpe Head of Molecular Neuroimmunology Laboratory IRCCS Fondazione Santa Lucia, Italy |
Microbiome in Pediatric Autism: can microbial intervention improve the social behaviour? |
| 4:10 – 4:35 pm | Dr. Nezar Al-Hebshi Associate Professor- Co Director, Oral Microbiome Research Laboratory Temple University, PA, USA |
Role of the Oral Microbiome in Health and Disease: can we quantify dysbiosis? |
| 4:35 – 5:00 pm | Prof. Marvin Edeas Department Endocrinology, Metabolism and Diabetes Université de Paris, INSERM, Institute Cochin, France |
Targeting Microbiota Dysbiosis: Barriers and Perspectives |
| 5:00 – 5:45 pm | Panel Discussion
Panel members: TBC
|
|
| 5:45 – 6:00 pm | Closing remarks for Day 1 | MENA Microbiome conference Chairs |
| 7:00 – 8:00 am | Registration/Check-in | |
| 8:00 am – 12:00 pm | Session IV: A deep dive into the human gut: Lessons from the Microbiome
Learning objectives:
Session Chairs:
|
|
| 8:00 – 8:45 am | Prof. Peer Bork Director of EMBL Heidelberg, Germany |
Keynote Lecture II:
Gut microbiome analysis for human health and wellbeing |
| 8:45 – 9:10 am | Prof. Emmanuelle Maguin Director, French National Institute for Agriculture, Food, and Environment (INRAE), France |
The food and microbiome interplay for health |
| 9:10 – 9:35 am | Dr. Mohammad Tauqeer Alam Assistant Professor, Biology Department, UAE University, UAE |
Identifying microbial markers for gut microbiome associated diseases using systems biology approaches |
| 9:35 – 10:00 am | Dr. Greg Tasian Attending Pediatric Urologist, Division of Urology Children’s Hospital of Philadelphia, PA, USA |
The Gut-Kidney Axis of Kidney Stone Disease: A Pathway to Novel Diagnostics and Therapeutics |
| 10:00 – 10:05 am | Patient Success story | Manipulation of the microbiome through diet can improve clinical outcomes: A story from an IBD-Autistic patient at Sidra Medicine |
| 10:05 – 10:35 am | Coffee break
Poster viewing and judging |
|
| 10:35 – 11:00 am | Prof. Nahla Mansour Professor of Microbial Molecular Biology National Research Center, Egypt |
Gut Microbiome Analysis in Type 2 Diabetes Egyptians: Towards Personalized Medicine |
| 11:00 – 11:25 am | TBC | TBC |
| 11:25 – 11:50 am | Prof. Mohammad Issa El Mouzan Professor of Pediatrics, College of Medicine, King Saud University, Saudi Arabia |
Gut Virome and Mycobiome in the Saudi pediatric population |
| 11:50 – 12:00 pm | Short Oral Talk | O4 |
| 12:00 – 12:10 pm | Short Oral Talk | O5 |
| 12:10 – 12:20 pm | Short Oral Talk | O6 |
| 12:20 – 1:30 pm | Lunch
Poster viewing and judging |
|
| 1:00 – 3:05 pm | Session V: Microbiome in Women and neonatal Health
Learning objectives: |
|
| 1:30 -1:55 pm | Prof. Phillip Bennett Director of Institute of Reproductive and Developmental Biology, Professor of Obstetrics and Gynaecology Imperial College London, UK |
Microbiome aspects of fertility, miscarriage, and preterm birth |
| 1:55 – 2:20 pm | Dr. Maha Al Asmakh Department Head of Biomedical Sciences Associate Professor, Qatar University, Qatar |
Salivary Microbiome in pregnancy |
| 2:20 – 2:45 pm | Prof. Erika Isolauri Professor of Pediatrics Head of the Department of Clinical Medicine, Faculty of Medicine, University of Turku, Finland |
Resilience to risk exposures in the preterm child through the microbiome |
| 2:45 – 3:10 pm | Dr. Ahmed Mustafa Sequencing Core Director of the Microbiome Center Children’s Hospital of Philadelphia, PA, USA |
Empowering Global Disease Surveillance: Leveraging Microbial Genomics, Big Data Mining, and Environmental Microbiome Analysis to Understand Infectious Diseases |
| 3:10 – 3:35 pm | Dr. Ibrahim Hassan Senior attending Physician, Microbiology and Virology, Sidra Medicine, Qatar |
Antimicrobial stewardship and microbiome in the pediatric population: Where are we? |
| 3:35 – 4:00 pm | Coffee Break
Poster viewing and judging |
|
| 4:00 – 5:30 pm | Microbiome Documentary Screening:
The Invisible Extinction |
Martin Blaser Professor, Medicine and Microbiology, Robert Wood Johnson Medical School, NJ, USA Maria Gloria Dominguez Bello |
| 5:30 – 5:45 pm | Closing remarks for Day 2 & Posters Award Announcement |
MENA Microbiome conference Chairs |